1030– 1130 hrs
The current times will go down in the history of India as the 75th year of our independence and also the year where India has demonstrated an unrivalled resilience, capability & capacity to take on this once-in-a-lifetime COVID pandemic, over the last 21 months and emerge from it as a stronger, more confident nation. The single most important dimension contributing to this incredible resilience has been "Digital".
With a strong foundation of digital infrastructure and expanded digital access through Digital India Programme of the Government, India is now poised for the next phase of growth.
The DX Summit 3.0 will witness some of the eminent Indian and International speakers and would witness leadership engagement, intensive deliberations on the most promising digital trends across the industry sectors which are Thriving in the New World Order.
Digital transformation offers biopharma, MedTech and life sciences companies - opportunities to execute efficiently, engage effectively, and innovate new products and services. Realizing opportunities through digital transformation requires an overall strategy: A digital foundation that can take advantage of emerging technologies—such as analytics, cognitive intelligence, blockchain, cloud, digital reality—harness data, and scale across the organization; a culture of collaboration and experimentation; and supportive leadership.
But developing and delivering a digital strategy is never an easy task. The tendency to manage digital initiatives in ways that take the form of projects or are limited to activities within a given division or function – do not yield transformational benefits. Life sciences companies that want to move away from that tendency, need to develop a digital DNA by which their digital activities; people, culture, and structure are aligned with the organization's broad ambition. That goal requires implementing unique and innovative strategies across all processes within the organization. This session will share the nuances of building a digital DNA, benefits and key challenges for the life sciences sector.
The day would focus on the innovative interventions witnessed by the Healthcare Sector with Plenary Sessions, fire side chat with experts, solution providers, MSME industry from the sector and all relevant stake holders.